Multi-Omics Analysis of Proteasome Inhibitor Resistance in Multiple Myeloma

被引：0

作者：

Han, Seungbin ^{[1
]}

Lee, Chien-Yun ^{[2
]}

Besse, Lenka ^{[3
,4
]}

Munawar, Umair ^{[1
]}

Besse, Andrej ^{[3
,4
]}

Hainold, Ann-Sohpie ^{[1
]}

Nerreter, Silvia ^{[1
]}

Vogt, Cornelia ^{[1
]}

Kurian, Shilpa ^{[1
]}

Zhou, Xiang ^{[1
]}

Haertle, Larissa ^{[1
]}

Waldschmidt, Johannes ^{[1
]}

Driessen, Christoph ^{[4
]}

Einsele, Hermann ^{[1
]}

Rasche, Leo ^{[1
]}

Kuster, Bernhard ^{[2
]}

机构：

[1] Univ Hosp Wuerzburg, Dept Internal Med 2, Wurzburg, Germany

[2] Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany

[3] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic

[4] Cantonal Hosp St Gallen, Div Oncol & Hematol, St Gallen, Switzerland

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-203352

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6817 / 6818

页数：2

共 50 条

[1] Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis
Poos, Alexandra
Prokoph, Nina
Przybilla, Moritz
Mallm, Jan-Philipp
Steiger, Simon
Seufert, Isabelle
John, Lukas
Tirier, Stephan
Bauer, Katharina
Baumann, Anja
Rohleder, Jennifer
Munawar, Umair
Rasche, Leo
Kortum, Martin
Giesen, Nicola
Reichert, Philipp
Huhn, Stefanie
Muller-Tidow, Carsten
Goldschmidt, Hartmut
Stegle, Oliver
Raab, Marc
Rippe, Karsten
Weinhold, Niels
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S14 - S15
[2] Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma
Zhuang, Yan
Li, Chenyu
Jiang, Hua
Li, Lu
Zhang, Yuanteng
Yu, Wei
Fu, Weijun
FRONTIERS IN ONCOLOGY, 2023, 13
[3] MyeloDB: a multi-omics resource for multiple myeloma
Kumar, Ambuj
Kumar, Keerthana Vinod
Kundal, Kavita
Sengupta, Avik
Sharma, Simran
Kunjulakshmi, R.
Kumar, Rahul
FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (01)
[4] MyeloDB: a multi-omics resource for multiple myeloma
Ambuj Kumar
Keerthana Vinod Kumar
Kavita Kundal
Avik Sengupta
Simran Sharma
Kunjulakshmi R
Rahul Kumar
Functional & Integrative Genomics, 2024, 24
[5] Multi-omics data integration reveals molecular targets of carfilzomib resistance in multiple myeloma
Huber, Julia
Malyutina, Alina
Bolomsky, Arnold
Zojer, Niklas
Schreder, Martin
Schneller, Anja
Pfeiffer, Christina
Miettinen, Juho
Tang, Jing
Heckman, Caroline
Ludwig, Heinz
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S92 - S93
[6] Comprehensive Multi-Omics Analysis of Gene Fusions in a Large Multiple Myeloma Cohort
Foltz, Steven M.
Gao, Qingsong
Yoon, Christopher J.
Weerasinghe, Amila
Sun, Hua
Yao, Lijun
Fiala, Mark A.
Kohnen, Daniel R.
King, Justin
Ju, Yeong Seok
DiPersio, John F.
Vij, Ravi
Ding, Li
BLOOD, 2018, 132
[7] SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
Heynen, Guus J. J. E.
Baumgartner, Francis
Heider, Michael
Patra, Upayan
Holz, Maximilian
Braune, Jan
Kaiser, Melanie
Schaeffer, Isabell
Bamopoulos, Stefanos A.
Ramberger, Evelyn
Murgai, Arunima
Ng, Yuen Lam Dora
Demel, Uta Margareta
Laue, Dominik
Liebig, Sven
Krueger, Josefine
Janz, Martin
Nogai, Axel
Schick, Markus
Mertins, Philipp
Mueller, Stefan
Bassermann, Florian
Kroenke, Jan
Keller, Ulrich
Wirth, Matthias
BLOOD ADVANCES, 2023, 7 (04) : 469 - 481
[8] Targeting Redox Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma
Dolloff, Nathan G.
Reyes, Leticia
Smith, Brittany
Langenheim, John Fairbanks
Manevich, Yefim
BLOOD, 2015, 126 (23)
[9] Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment
Zheng, Bo
Yi, Ke
Zhang, Yajun
Pang, Tongfang
Zhou, Jieyi
He, Jie
Lan, Hongyan
Xian, Hongming
Li, Rong
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3833 - 3846
[10] Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment
Bo Zheng
Ke Yi
Yajun Zhang
Tongfang Pang
Jieyi Zhou
Jie He
Hongyan Lan
Hongming Xian
Rong Li
Clinical and Experimental Medicine, 2023, 23 : 3833 - 3846

← 1 2 3 4 5 →